^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SHR7280
i
Other names: SHR7280, SHR 7280, SHR-7280
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Jiangsu Hengrui Pharma
Drug class:
GnRH antagonist
Related drugs:
3ms
To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects (clinicaltrials.gov)
P3, N=317, Completed, Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting --> Completed | Trial primary completion date: Oct 2024 --> May 2025
Trial completion • Trial primary completion date • Head-to-Head
|
SHR7280
3ms
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects (clinicaltrials.gov)
P1, N=20, Completed, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Completed
Trial completion
|
SHR7280 • midazolam hydrochloride
4ms
A Trial of SHR7280 in Healthy Subjects (clinicaltrials.gov)
P1, N=16, Completed, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Completed
Trial completion
|
SHR7280
7ms
A Trial of SHR7280 in Healthy Subjects (clinicaltrials.gov)
P1, N=16, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
New P1 trial
|
SHR7280
7ms
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects (clinicaltrials.gov)
P1, N=20, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
New P1 trial
|
SHR7280 • midazolam hydrochloride
over1year
To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects (clinicaltrials.gov)
P3, N=317, Active, not recruiting, Jiangsu HengRui Medicine Co., Ltd. | Recruiting --> Active, not recruiting
Enrollment closed • Head-to-Head
|
SHR7280
over1year
A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (clinicaltrials.gov)
P1, N=6, Completed, Jiangsu HengRui Medicine Co., Ltd. | Recruiting --> Completed
Trial completion
|
SHR7280
over1year
The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis. (clinicaltrials.gov)
P1/2, N=179, Completed, Jiangsu HengRui Medicine Co., Ltd. | Recruiting --> Completed | Trial completion date: Jan 2024 --> May 2024 | Trial primary completion date: Jan 2024 --> May 2024
Trial completion • Trial completion date • Trial primary completion date
|
SHR7280
over1year
A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (clinicaltrials.gov)
P1, N=8, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Recruiting
Enrollment open
|
SHR7280
over1year
A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (clinicaltrials.gov)
P1, N=8, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
New P1 trial
|
SHR7280
almost2years
Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART) (clinicaltrials.gov)
P2, N=85, Completed, Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting --> Completed | Trial completion date: Mar 2023 --> Aug 2023 | Trial primary completion date: Dec 2022 --> Aug 2023
Trial completion • Trial completion date • Trial primary completion date
|
SHR7280
almost2years
A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (clinicaltrials.gov)
P1, N=16, Completed, Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting --> Completed
Trial completion
|
SHR7280
Share via
